A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye

NCT01791426 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Adjustment of company focus due to acquision by Valeant Pharmaceuticals

Conditions

Dry Eye

Interventions

DEVICE: Artelac Rebalance
DEVICE: Vismed

Sponsor

Bausch & Lomb Incorporated